Atossa Genetics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$6.7 |
Market Cap |
$20.88 M |
Shares Outstanding |
9.12 M |
Public Float |
5.43 M |
Address |
107 Spring Street Seattle Washington 98104 United States |
Employees | - |
Website | http://www.atossagenetics.com |
Updated | 07/08/2019 |
Atossa Genetics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. |